BRIEF published on 02/20/2025 at 06:50, 9 months 13 days ago Krones AG Reports Robust Financial Growth in 2024 EBITDA Margin Krones AG Financial Growth 2024 Performance 2025 Forecast
PRESS RELEASE published on 02/20/2025 at 06:45, 9 months 13 days ago Krones improved all key financial figures in 2024 – Executive Board forecasts continuation of profitable growth in 2025 Krones AG improved all key financial figures in 2024, forecasts continuation of profitable growth in 2025 despite challenging global economic conditions Profitable Growth Financial Figures 2024 Krones AG 2025
BRIEF published on 11/05/2024 at 06:50, 1 year 1 month ago Krones Showcases Strong Revenue and Profitability Growth in 2024 Revenue Growth EBITDA Margin Order Intake Free Cash Flow ROCE Improvement
PRESS RELEASE published on 11/05/2024 at 06:45, 1 year 1 month ago Krones significantly improves revenue and profitability in first three quarters of 2024 Krones AG significantly improves revenue and profitability in the first three quarters of 2024, exceeding expectations. Company maintains strong growth momentum Financial Results Revenue Profitability Growth Krones AG Guidance
BRIEF published on 07/31/2024 at 06:50, 1 year 4 months ago Krones AG Reports Strong First Half of 2024 Revenue Growth Profitability EBITDA Margin Order Intake Free Cash Flow
PRESS RELEASE published on 07/31/2024 at 06:45, 1 year 4 months ago Krones reports very good first half-year 2024 – significant increase in revenue and profitability Krones AG reports significant revenue and profitability increase in first half-year 2024. Order intake and revenue growth surpass prior year levels. EBITDA margin rises to 10.0% Revenue Increase Profitability EBITDA Margin Krones AG First Half-year 2024
BRIEF published on 07/03/2024 at 18:10, 1 year 5 months ago Krones Aims for Significant Growth by 2028 Revenue Growth Sustainability Financial Targets Digitalisation Krones AG
PRESS RELEASE published on 07/03/2024 at 18:05, 1 year 5 months ago Krones to continue profitable growth – medium-term targets set for 2028 Krones AG plans to continue profitable growth, setting medium-term targets for 2028, including a revenue increase to €7 billion and an EBITDA margin target between 11% and 13% Revenue Increase EBITDA Margin Profitable Growth Krones AG Medium-term Targets
BRIEF published on 05/03/2024 at 06:50, 1 year 7 months ago Krones AG Reports Strong Q1 2024 Performance, Confirms Full-Year Guidance Revenue Growth Krones AG Profitability Increase Q1 2024 Financial Results Full-year Guidance
PRESS RELEASE published on 05/03/2024 at 06:45, 1 year 7 months ago Krones continues profitable growth path Krones AG reports continued profitable growth path in the first quarter of 2024, with strong order intake and revenue increase. EBITDA margin improved to 10.1%. The company confirms full-year financial targets for 2024 Revenue Increase EBITDA Margin Profitable Growth Krones AG Financial Targets For 2024
Published on 12/05/2025 at 02:35, 4 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
